Abstract:Circulation, Volume 146, Issue Suppl_1, Page A12876-A12876, November 8, 2022. Introduction:Heart failure (HF) is characterized by a switch from predominantly fatty acid (FA) to glucose metabolism, but the molecular pathways involved in this switch are not totally understood. Identification of novel pathways regulating cellular metabolism could facilitate the development of new therapies. Tristetraprolin (TTP) is a tandem zinc finger protein that binds to AU-rich elements (AREs) in the 3' untranslated region (UTR) of mRNA molecules and causes their degradation. Its expression is regulated by mTOR, a key protein involved in cellular metabolism. Our preliminary data suggested a link between TTP and FA metabolism in the heart. Thus, we hypothesized that TTP regulates cardiac FA metabolism and that its deletion prevents the development of HF by increasing FA uptake and metabolism in the heart.Results:TTP downregulation in cultured cardiomyocytes resulted in higher palmitate uptake and oxidation, while its overexpression had the opposite effect. Since TTP regulates its targets at the mRNA level, we studied the mRNA levels of ARE-containing genes involved in lipid metabolism, and found that only PPARα mRNA to be significantly increased with TTP downregulation. Furthermore, we demonstrated that TTP physically interacts with PPARα mRNA, and the activity of a luciferase reporter harboring full-length PPARα 3'UTR is increased with TTP downregulation. Additionally, PPARα mRNA is stabilized with TTP knockdown. We then studied the role of TTP in cardiac FA metabolism using mice with cardiac-specific (cs) TTP knockout (KO). Consistent with our in vitro data, cs-TTP KO mice displayed higher fatty acid utilization compared to littermate controls but maintained normal cardiac function at baseline. We also demonstrated a significantly higher TTP levels in failing human and mouse cardiac samples, suggesting that TTP levels are altered in HF.Conclusion:Our results demonstrate that TTP is a novel regulator of cardiac FA metabolism through its effect on PPARα, and that its levels are increased in HF. Thus, modulation of TTP may be a viable therapeutic approach for HF.

Bone marrow deficiency of mRNA decaying protein Tristetraprolin increases inflammation and mitochondrial ROS but reduces hepatic lipoprotein production in LDLR knockout mice

Abstract 12876: Post-Transcriptional Regulation of Cardiac Fatty Acid Metabolism by the Tandem Zinc Finger Mrna Binding Protein Tristetraprolin

Tristetraprolin promotes survival of mammary progenitor cells by restraining TNFα levels

RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-κB Signaling*

mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function

TTP protects against acute liver failure by regulating CCL2 and CCL5 through m6A RNA methylation

Suppression of IL-12 Production by Tristetraprolin through Blocking NF-кB Nuclear Translocation

Tristetraprolin Specifically Regulates the Expression and Alternative Splicing of Immune Response Genes in HeLa Cells

Abstract 148: Lipoprotein Lipase Deficiency Reprograms Bone Marrow Cellular Metabolic Activity And Inflammatory Responses

Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin

Gene Suppression by Tristetraprolin and Release by the P38 Pathway

Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice.

Tristetraprolin Down-Regulation Contributes to Persistent TNF-Alpha Expression Induced by Cigarette Smoke Extract through a Post-Transcriptional Mechanism

PTPRO Promotes Oxidized Low-Density Lipoprotein Induced Oxidative Stress and Cell Apoptosis through Toll-Like Receptor 4/Nuclear Factor κB Pathway.

MK2 Posttranscriptionally Regulates TNF-α-induced Expression of ICAM-1 and IL-8 Via Tristetraprolin in Human Pulmonary Microvascular Endothelial Cells.

Enhanced Atherosclerosis in TIPE2-deficient Mice is Associated with Increased Macrophage Responses to Oxidized Low-Density Lipoprotein.

Trbp Regulates Heart Function Through Microrna-Mediated Sox6 Repression

The Binding Capability of Plasma Phospholipid Transfer Protein, but Not Hdl Pool Size, is Critical to Repress Lps Induced Inflammation

Dysregulation of lipid metabolism in the liver of Tspo knockout mice

Targeting Tristetraprolin Expression or Functional Activity Regulates Inflammatory Response Induced by MSU Crystals

PTPN2 Negatively Regulates Macrophage Inflammation in Atherosclerosis